1 |
High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients |
|
|
| Wanjin Chen, Shouwen Wang, Hongchuan Zhao, Guobin Wang, Rong Qin, Fan Huang, Wei Geng, Zimei Liu, Wei Wang, Ruolin Wu, Liujin Hou, Zhenghui Ye, Xinghua Zhang, Xiaoping Geng, Xiaojun Yu |
|
| Scandinavian Journal of Gastroenterology. 2023; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Understanding the mechanisms of gallbladder lesions: A systematic review |
|
|
| Andrei Bojan, Liliana Foia, Maria Vladeanu, Iris Bojan, Carmen Plesoianu, Alexandru Plesoianu, Catalin Pricop |
|
| Experimental and Therapeutic Medicine. 2022; 24(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Presentation and surgical management of xanthogranulomatous cholecystitis |
|
|
| Maximos Frountzas, Dimitrios Schizas, Efstathia Liatsou, Konstantinos P Economopoulos, Christina Nikolaou, Konstantinos G Apostolou, Konstantinos G Toutouzas, Evangelos Felekouras |
|
| Hepatobiliary & Pancreatic Diseases International. 2021; 20(2): 117 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Choledochal Cysts Resected during Childhood Show No Mutations of KRAS and BRAF as Early Markers of Malignancy in Cholangiocytes |
|
|
| Marie Uecker, Ulrich Lehmann, Peter Braubach, Nagoud Schukfeh, Omid Madadi-Sanjani, Benno M. Ure, Claus Petersen, Joachim F. Kuebler |
|
| European Journal of Pediatric Surgery. 2021; 31(01): 020 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Novel immunotherapy strategies for hepatobiliary cancers |
|
|
| Thomas T DeLeon, Yumei Zhou, Bolni M Nagalo, Raquel T Yokoda, Daniel H Ahn, Ramesh K Ramanathan, Marcela A Salomao, Bashar A Aqel, Amit Mahipal, Tanios S Bekaii-Saab, Mitesh J Borad |
|
| Immunotherapy. 2018; 10(12): 1077 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Xanthogranulomatous cholecystitis: A clinicopathological study of its association with gallbladder carcinoma |
|
|
| Peng Yuan Zhuang,Ming Jie Zhu,Jian Dong Wang,Xue Ping Zhou,Zhi Wei Quan,Jun Shen |
|
| Journal of Digestive Diseases. 2013; 14(1): 45 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Xanthogranulomatous cholecystitis: a European and global perspective |
|
|
| Matthew David Hale,Keith J Roberts,James Hodson,Nigel Scott,Maria Sheridan,Giles J Toogood |
|
| HPB. 2013; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Xanthogranulomatous cholecystitis: A clinicopathological study of its association with gallbladder carcinoma |
|
|
| Zhuang, P.Y. and Zhu, M.J. and Wang, J.D. and Zhou, X.P. and Quan, Z.W. and Shen, J. |
|
| Journal of Digestive Diseases. 2013; 14(1): 45-50 |
|
| [Pubmed] [Google Scholar] |
|
9 |
Diagnosis and management of gallbladder cancer |
|
|
| Andrén-Sandberg, A. |
|
| North American Journal of Medical Sciences. 2012; 4(7): 293-299 |
|
| [Pubmed] [Google Scholar] |
|
10 |
Gallbladder cancer: Can newer insights improve the outcome? |
|
|
| Dutta, U. |
|
| Journal of Gastroenterology and Hepatology. 2012; 27(4): 642-653 |
|
| [Pubmed] [Google Scholar] |
|
11 |
Gallbladder cancer: Can newer insights improve the outcome? |
|
|
| Usha Dutta |
|
| Journal of Gastroenterology and Hepatology. 2012; 27(4): 642 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Gallbladder mucosal changes associated with chronic cholecystitis and their relationship with carcinoma gallbladder |
|
|
| Kaur, A. and Dubey, V.K. and Mehta, K.S. |
|
| JK Science. 2011; 14(2): 89-92 |
|
| [Pubmed] [Google Scholar] |
|